Kornerup H J, Korsager S
Ugeskr Laeger. 1989 Apr 3;151(14):890-2.
A material of 76 patients from general practice treated with diuretics for mild to moderate hypertension were randomized to supplementary treatment with captopril (39 patients) and metoprolol (37 patients), respectively, on account of diastolic blood pressure greater than or equal to 95 mmHg. Satisfactory regulation of the blood pressure (diastolic blood pressure less than or equal to 90 mmHg) and acceptable wellbeing was obtained in 29 patients in the captopril group and in 23 patients in the metoprolol group. Six patients in the captopril group were excluded on account of absence of effect on the blood pressure and four dropped out on account of side effects. In the metoprolol group, nine patients were excluded on account of absence of effect on the blood pressure and five on account of side effects. This difference was not significant. In the captopril group, 14 side effects were registered in eight patients while 23 side effects were observed in 15 patients in the metoprolol group. This difference was not statistically significant, p greater than 0.05 (risk for type 2 error = 60%). It is concluded that captopril + a diuretic is just as effective a form of treatment of slight to moderate hypertension as metoprolol + a diuretic and that treatment with captopril + a diuretic is associated with so few side effects that it may be considered as an alternative first choice of treatment in cases of slight to moderate hypertension.
76例因轻度至中度高血压而接受利尿剂治疗的全科医疗患者,由于舒张压大于或等于95mmHg,被随机分为卡托普利补充治疗组(39例)和美托洛尔补充治疗组(37例)。卡托普利组29例患者和美托洛尔组23例患者血压得到满意控制(舒张压小于或等于90mmHg)且健康状况可接受。卡托普利组6例患者因对血压无影响被排除,4例因副作用退出。美托洛尔组9例患者因对血压无影响被排除,5例因副作用退出。这种差异无统计学意义。卡托普利组8例患者出现14种副作用,美托洛尔组15例患者出现23种副作用。这种差异无统计学意义,p大于0.05(Ⅱ类错误风险=60%)。结论是,卡托普利+利尿剂治疗轻度至中度高血压与美托洛尔+利尿剂一样有效,且卡托普利+利尿剂治疗的副作用极少,在轻度至中度高血压病例中可被视为替代的首选治疗方法。